| 1. Ach | acetylcholine |
| 2. APUD | Amine Precursor Uptake and Decarboxylation |
| 3. CCK | cholecystokinin |
| 4. CCK-RF | CCK-releasing factor |
| 5. CRTZ (or CTZ) | chemoreceptor trigger zone |
| 6. DAG | diacylglycerol |
| 7. EAS | external anal sphincter |
| 8. EPI | exocrine pancreatic insufficiency |
| 9. EPSP | excitatory postsynaptic potential |
| 10. FA | fatty acid |
| 11. GDV | gastric dilatation/volvulus |
| 12. GIP | gastric inhibitory peptide (or glucose-dependent insulin-releasing peptide) |
| 13. GRP | gastrin releasing peptide (very similar to bombesin) |
| 14. IAS | internal anal sphincter |
| 15. ICS | ileocecal sphincter |
| 16. IP3 | inositol triphosphate |
| 17. IPSP | inhibitory postsynaptic potential |
| 18.LCFA | long chain fatty acid |
| 19.LCTG | long chain triglyceride |
| 20. LES | lower esophageal sphincter |
| 21. MCFA | medium chain fatty acid |
| 22. MCT | medium chain triglyceride |
| 23. MG | monoglyceride |
| 24. MMC | migrating motor complex (or Phase III or housekeeper) |
| 25. NANC | nonadrenergic noncholinergic transmitter |
| 6. NO | nitric oxide |
| 27. PRAA | persistent right aortic arch |
| 28. SCFA | short chain fatty acid |
| 29. SP | substance P |
| 30. SS | somatostatin |
| 31. TLI | trypsin-like immunoreactivity |
| 32. UES | upper esophageal |
| 33. VIP: | vasoactive intestinal peptide |